首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement.
【2h】

Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement.

机译:使用连续细胞系和新鲜血清增强剂对甲型和乙型流感以及副流感1和2型病毒进行微中和测试。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A modified microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses was developed. Use of continuous cell lines (Madin-Darby canine kidney and LLC-MK2), hemagglutination for virus detection, and transfer plates and other microtiter equipment resulted in a highly mechanized technique suitable for titrating large numbers of sera easily and relatively inexpensively. Titers of heat-inactivated human sera were enhanced 0.5 to 3.5 log2 by addition of fresh hamster or human serum to the test. Seroconversion rates and identification of seronegative persons were not changed by fresh serum enhancement, but the magnitude of seroconversion was often increased and the distribution of positive titers was broadened. For influenza A and B, seroconversion rates in the microneutralization test were equivalent to those obtained in rhesus monkey kidney tube neutralization tests. For influenza B, seroconversion rates by micro-neutralization were almost double those obtained with the hemagglutination inhibition test, but the rates were similar for influenza A/USSR (H1N1). Preexisting microneutralization titers correlated well with resistance of infection with influenza B. Limited experience with parainfluenza 1 and 2 was similar to previously reported findings with the tube neutralization test.
机译:已开发了针对甲型和乙型流感以及副流感1和2型病毒的改良微中和测试。使用连续细胞系(Madin-Darby犬肾和LLC-MK2),血凝检测病毒以及转移板和其他微量滴定仪导致了高度机械化的技术,可轻松,相对廉价地滴定大量血清。通过添加新鲜的仓鼠或人血清,将热灭活的人血清滴度提高0.5至3.5 log2。血清新鲜转化没有改变血清转化率和血清阴性患者的身份,但血清转化的幅度通常会增加,阳性滴度的分布会加宽。对于甲型和乙型流感,微量中和试验中的血清转化率与恒河猴肾管中和试验中的血清转化率相同。对于乙型流感,通过微中和的血清转化率几乎是通过血凝抑制试验获得的血清转化率的两倍,但对于甲型/苏联(H1N1)流感,其转化率相似。预先存在的微量中和效价与乙型流感病毒的感染抵抗力密切相关。副流感1和2的有限经验与先前报告的试管中和结果相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号